Search research articles
Contact Us
Filters
Showing results (51-60 of 229) with videos related to
Page
of 23
Sort By:
Expert Review of Anticancer Therapy
|
September 13, 2013
The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinoma
F Stenner-Liewen, V Grünwald, R Greil, et al.
Acta Chirurgica Belgica
|
May 1, 1972
[Our experience in the surgical treatment of chronic pancreatitis]
T Rock, G C Porta, U D'Alonzo, et al.
Archives of Virology
|
January 1, 1989
Limitations of different ELISA procedures for localizing epitopes in viral coat protein subunits
E L Dekker, C Porta, M H Van Regenmortel
International Journal of Cancer
|
December 15, 1979
An assay for estradiol preceptors using a staphylococcal protein-A--estradiol antibody adsorbent
E Ronchi, C Porta, G Di Fronzo, et al.
Autonomic Neuroscience : Basic & Clinical
|
August 4, 2001
Modulatory effects of respiration
L Bernardi, C Porta, A Gabutti, et al.
Oncology Reports
|
May 19, 2011
Intrahepatic fluorodeoxyuridine to treat unresectable hepatocellular carcinoma patients
G Nastasi, C Porta, M Moroni, et al.
Anticancer Research
|
September 1, 1996
Antioxidant enzymatic system and free radicals pathway in two different human cancer cell lines
C Porta, M Moroni, P Guallini, et al.
Histology and Histopathology
|
January 1, 1992
Scrotal angiokeratoma (Fordyce): histopathological and ultrastructural findings
L Gioglio, C Porta, M Moroni, et al.
Cancer Research
|
December 29, 1998
Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas
C Ghigna, M Moroni, C Porta, et al.
Oncology Reports
|
May 21, 2011
Inadequacy of combined 5-Fluorouracil, very-high-dose leucovorin, mitomycin-C and Cisplatin as 2nd-line therapy for advanced colon-cancer
G Nastasi, C Porta, M Moroni, et al.
Page
of 23
Search research articles
Search
Showing results (51-60 of 229) with videos related to
Sort By:
Page
of 23
Expert Review of Anticancer Therapy
|
September 13, 2013
The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinoma
F Stenner-Liewen, V Grünwald, R Greil, et al.
Acta Chirurgica Belgica
|
May 1, 1972
[Our experience in the surgical treatment of chronic pancreatitis]
T Rock, G C Porta, U D'Alonzo, et al.
Archives of Virology
|
January 1, 1989
Limitations of different ELISA procedures for localizing epitopes in viral coat protein subunits
E L Dekker, C Porta, M H Van Regenmortel
International Journal of Cancer
|
December 15, 1979
An assay for estradiol preceptors using a staphylococcal protein-A--estradiol antibody adsorbent
E Ronchi, C Porta, G Di Fronzo, et al.
Autonomic Neuroscience : Basic & Clinical
|
August 4, 2001
Modulatory effects of respiration
L Bernardi, C Porta, A Gabutti, et al.
Oncology Reports
|
May 19, 2011
Intrahepatic fluorodeoxyuridine to treat unresectable hepatocellular carcinoma patients
G Nastasi, C Porta, M Moroni, et al.
Anticancer Research
|
September 1, 1996
Antioxidant enzymatic system and free radicals pathway in two different human cancer cell lines
C Porta, M Moroni, P Guallini, et al.
Histology and Histopathology
|
January 1, 1992
Scrotal angiokeratoma (Fordyce): histopathological and ultrastructural findings
L Gioglio, C Porta, M Moroni, et al.
Cancer Research
|
December 29, 1998
Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas
C Ghigna, M Moroni, C Porta, et al.
Oncology Reports
|
May 21, 2011
Inadequacy of combined 5-Fluorouracil, very-high-dose leucovorin, mitomycin-C and Cisplatin as 2nd-line therapy for advanced colon-cancer
G Nastasi, C Porta, M Moroni, et al.
Page
of 23